MYCO-007
MYCO-007 is an MDMA-like entactogen that is under development for the treatment of psychiatric disorders.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
MYCO-007 is an MDMA-like entactogen that is under development for the treatment of psychiatric disorders. It is a short-acting MDMA analogue. MYCO-007 is being developed by Mydecine.
As of February 2024, it is in preclinical research. The chemical structure of MYCO-007 does not yet appear to have been disclosed. (MY100) and (MY101) were described in Mydecine's patent for short-acting MDMA analogues
See also
MYCO-002 MYCO-006 List of investigational hallucinogens and entactogens
Text derived from https://en.wikipedia.org/w/index.php?oldid=1372023369 under CC BY-SA 4.0; modifications have been made.